The FDA is clear on this, you can either:
1. Get excellent clinical efficacy results with no safety issues and they don't really care about replicating the mechanism of action in-vivo with in-vitro, or;
2.
Source: https://pink.citeline.com/-/media/supporting-documents/pink-sheet/2020/08/fda-briefing-document-on-remestemcel-l-am-session.pdf?rev=222f51497a0f49c294091e6ad844115c&hash=93D88D09ED488698D719E3EA21DD7334
- Forums
- ASX - By Stock
- The Phase I/IIb Nereid Study Is Now Registered
The FDA is clear on this, you can either:1. Get excellent...
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.72M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 20.0¢ | $24.56K | 121.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 40000 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 151207 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 40000 | 0.200 |
1 | 8187 | 0.195 |
2 | 45790 | 0.190 |
3 | 102017 | 0.185 |
1 | 51937 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 151207 | 3 |
0.215 | 2183 | 1 |
0.220 | 162191 | 6 |
0.225 | 20000 | 1 |
0.230 | 15037 | 1 |
Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
Last
21.0¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
20.0¢ | 21.0¢ | 20.0¢ | 47440 | ||
Last updated 15.59pm 30/04/2024 ? |
Featured News
CYP (ASX) Chart |